{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:24:49Z","timestamp":1785936289839,"version":"3.56.0"},"reference-count":103,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Epstein\u2013Barr Virus (EBV) and Kaposi\u2019s sarcoma associated-herpesvirus (KSHV) are \u03b3-herpesviruses that belong to the Herpesviridae family. EBV infections are linked to the onset and progression of several diseases, such as Burkitt lymphoma (BL), nasopharyngeal carcinoma (NPC), and lymphoproliferative malignancies arising in post-transplanted patients (PTDLs). KSHV, an etiologic agent of Kaposi\u2019s sarcoma (KS), displays primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD). Many therapeutics, such as bortezomib, CHOP cocktail medications, and natural compounds (e.g., quercetin or curcumin), are administrated to patients affected by \u03b3-herpesvirus infections. These drugs induce apoptosis and autophagy, inhibiting the proliferative and cell cycle progression in these malignancies. In the last decade, many studies conducted by scientists and clinicians have indicated that nanotechnology and nanomedicine could improve the outcome of several treatments in \u03b3-herpesvirus-associated diseases. Some drugs are entrapped in nanoparticles (NPs) expressed on the surface area of polyethylene glycol (PEG). These NPs move to specific tissues and exert their properties, releasing therapeutics in the cell target. To treat EBV- and KSHV-associated diseases, many studies have been performed in vivo and in vitro using virus-like particles (VPLs) engineered to maximize antigen and epitope presentations during immune response. NPs are designed to improve therapeutic delivery, avoiding dissolving the drugs in toxic solvents. They reduce the dose-limiting toxicity and reach specific tissue areas. Several attempts are ongoing to synthesize and produce EBV vaccines using nanosystems.<\/jats:p>","DOI":"10.3390\/ijms222111407","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:18:09Z","timestamp":1634894289000},"page":"11407","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nanotechnology Frontiers in \u03b3-Herpesviruses Treatments"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2758-5120","authenticated-orcid":false,"given":"Marisa","family":"Granato","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Roma, RM, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF01317276","article-title":"The family Herpesviridae: An update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses","volume":"123","author":"Roizmann","year":"1992","journal-title":"Arch. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1128\/JVI.00622-06","article-title":"Antibodies to gp350\/220 enhance the ability of Epstein-Barr virus to infect epithelial cells","volume":"80","author":"Turk","year":"2006","journal-title":"J. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0042-6822(77)90292-6","article-title":"Efficiency of transformation of lymphocytes by Epstein-Barr virus","volume":"76","author":"Henderson","year":"1977","journal-title":"Virology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1084\/jem.145.4.948","article-title":"Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: Tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses","volume":"145","author":"Miller","year":"1977","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nrmicro2015","article-title":"The curious case of the tumour virus: 50 years of Burkitt\u2019s lymphoma","volume":"6","author":"Allday","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: More than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"19533","DOI":"10.1038\/srep19533","article-title":"The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A\/TGFbeta and beta1 integrin signalling","volume":"6","author":"Morris","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.semdp.2015.02.021","article-title":"Nasopharyngeal carcinoma: A review","volume":"32","author":"Petersson","year":"2015","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_9","first-page":"151","article-title":"EBV Persistence--Introducing the Virus","volume":"390","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hawkins, J.B., Delgado-Eckert, E., Thorley-Lawson, D.A., and Shapiro, M. (2013). The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003685"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.4049\/jimmunol.165.6.2975","article-title":"EBV persistence involves strict selection of latently infected B cells","volume":"165","author":"Joseph","year":"2000","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1128\/JVI.79.24.15430-15442.2005","article-title":"Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: Possible role in nasopharyngeal carcinoma metastasis","volume":"79","author":"Pegtel","year":"2005","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1128\/jvi.65.3.1245-1254.1991","article-title":"When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates","volume":"65","author":"Hurley","year":"1991","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1128\/jvi.65.7.3958-3963.1991","article-title":"The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA","volume":"65","author":"Hurley","year":"1991","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1074-7613(02)00318-7","article-title":"The dispersal of mucosal memory B cells: Evidence from persistent EBV infection","volume":"16","author":"Laichalk","year":"2002","journal-title":"Immunity"},{"key":"ref_16","first-page":"65","article-title":"EBV replication enzymes","volume":"258","author":"Tsurumi","year":"2001","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/rmv.441","article-title":"Latent and lytic Epstein-Barr virus replication strategies","volume":"15","author":"Tsurumi","year":"2005","journal-title":"Rev. Med. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/rmv.1780","article-title":"Switching of EBV cycles between latent and lytic states","volume":"24","author":"Murata","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-981-10-7230-7_17","article-title":"EBV-Encoded Latent Genes","volume":"1045","author":"Kanda","year":"2018","journal-title":"Adv. Exp. Med. Biol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00430-018-0570-1","article-title":"Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis","volume":"208","author":"Yin","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_21","first-page":"3","article-title":"Ebna1","volume":"391","author":"Frappier","year":"2015","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-0-387-70630-6_14","article-title":"LMP1 TRAFficking activates growth and survival pathways","volume":"597","author":"Soni","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Nkosi, D., Sun, L., Duke, L.C., and Meckes, D.G. (2020). Epstein-Barr virus LMP1 manipulates the content and functions of extracellular vesicles to enhance metastatic potential of recipient cells. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1009023"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e00589-20","DOI":"10.1128\/mBio.00589-20","article-title":"Epstein-Barr Virus LMP1 Promotes Syntenin-1- and Hrs-Induced Extracellular Vesicle Formation for Its Own Secretion To Increase Cell Proliferation and Migration","volume":"11","author":"Nkosi","year":"2020","journal-title":"mBio"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2007.11.011","article-title":"Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais","volume":"42","author":"Tiwawech","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2012.01.004","article-title":"The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)","volume":"22","author":"Dawson","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-62703-357-2_16","article-title":"EBER in situ hybridization for Epstein-Barr virus","volume":"999","author":"Weiss","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1099\/0022-1317-73-12-3169","article-title":"Expression of genes for the Epstein-Barr virus small RNAs EBER-1 and EBER-2 in Daudi Burkitt\u2019s lymphoma cells: Effects of interferon treatment","volume":"73","author":"Clarke","year":"1992","journal-title":"J. Gen. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1309\/MMAU-0QYH-7BHA-W8C2","article-title":"Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma","volume":"117","author":"Gulley","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0404.2010.01410.x","article-title":"EBNA1 and LMP1 variants in multiple sclerosis cases and controls","volume":"124","author":"Simon","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1128\/JVI.79.6.3713-3727.2005","article-title":"Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: Interactions with BFRF1 and with the nuclear lamina","volume":"79","author":"Gonnella","year":"2005","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11913","DOI":"10.1128\/JVI.01100-08","article-title":"Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production","volume":"82","author":"Lee","year":"2008","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/JVI.01099-08","article-title":"Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway","volume":"83","author":"Wang","year":"2009","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.virol.2005.11.046","article-title":"Regulation of the expression of the Epstein-Barr virus early gene BFRF1","volume":"347","author":"Granato","year":"2006","journal-title":"Virology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1128\/JVI.02436-07","article-title":"Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles","volume":"82","author":"Granato","year":"2008","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e01498-19","DOI":"10.1128\/JVI.01498-19","article-title":"The Novel Nuclear Targeting and BFRF1-Interacting Domains of BFLF2 Are Essential for Efficient Epstein-Barr Virus Virion Release","volume":"94","author":"Dai","year":"2020","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1128\/JVI.00473-06","article-title":"Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes","volume":"80","author":"Feederle","year":"2006","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1128\/jvi.68.11.7628-7633.1994","article-title":"Activation of the Epstein-Barr virus BMRF1 and BZLF1 promoters by ZEBRA in Saccharomyces cerevisiae","volume":"68","author":"Countryman","year":"1994","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/jvi.65.8.4033-4041.1991","article-title":"ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter","volume":"65","author":"Taylor","year":"1991","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0042-6822(90)90331-K","article-title":"Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP\/BZLF1 plasmids","volume":"178","author":"Gradoville","year":"1990","journal-title":"Virology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/jvi.63.4.1721-1728.1989","article-title":"Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses","volume":"63","author":"Taylor","year":"1989","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1128\/jvi.61.12.3672-3679.1987","article-title":"Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency","volume":"61","author":"Countryman","year":"1987","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/1878-0261.12641","article-title":"NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myeloma","volume":"14","author":"Xia","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1038\/s41598-017-13533-7","article-title":"Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy","volume":"7","author":"Granato","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1080\/15548627.2015.1091911","article-title":"The activation of KSHV lytic cycle blocks autophagy in PEL cells","volume":"11","author":"Granato","year":"2015","journal-title":"Autophagy"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Purushothaman, P., Uppal, T., Sarkar, R., and Verma, S.C. (2016). KSHV-Mediated Angiogenesis in Tumor Progression. Viruses, 8.","DOI":"10.3390\/v8070198"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fmicb.2016.00054","article-title":"KSHV Genome Replication and Maintenance","volume":"7","author":"Purushothaman","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-981-10-7230-7_14","article-title":"KSHV Genome Replication and Maintenance in Latency","volume":"1045","author":"Ueda","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.3390\/v6124961","article-title":"KSHV LANA\u2014The master regulator of KSHV latency","volume":"6","author":"Uppal","year":"2014","journal-title":"Viruses"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fmicb.2016.00334","article-title":"Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA","volume":"7","author":"Wei","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2018-05-848671","article-title":"Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease","volume":"132","author":"Fajgenbaum","year":"2018","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1158\/0008-5472.CAN-17-2321","article-title":"TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway","volume":"77","author":"Gruffaz","year":"2017","journal-title":"Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.3390\/v6093472","article-title":"Contribution of viral mimics of cellular genes to KSHV infection and disease","volume":"6","author":"Sakakibara","year":"2014","journal-title":"Viruses"},{"key":"ref_54","first-page":"951","article-title":"Interleukin-6 Family Cytokines","volume":"10","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/14740338.2018.1513487","article-title":"The safety of bortezomib for the treatment of multiple myeloma","volume":"17","author":"Beksac","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00277-021-04404-3","article-title":"Treatment of relapsed\/refractory multiple myeloma in the bortezomib and lenalidomide era: A systematic review and network meta-analysis","volume":"100","author":"Arcuri","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1042\/BSR20170304","article-title":"Efficacy and safety of bortezomib maintenance in patients with newly diagnosed multiple myeloma: A meta-analysis","volume":"37","author":"Sun","year":"2017","journal-title":"Biosci Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"12499","DOI":"10.1128\/JVI.01898-13","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus K7 modulates Rubicon-mediated inhibition of autophagosome maturation","volume":"87","author":"Liang","year":"2013","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.biocel.2016.09.006","article-title":"Concomitant reduction of c-Myc expression and PI3K\/AKT\/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt\u2019s lymphoma","volume":"79","author":"Granato","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41392-020-00376-4","article-title":"Targeting the signaling in Epstein-Barr virus-associated diseases: Mechanism, regulation, and clinical study","volume":"6","author":"Cao","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13027-020-00317-4","article-title":"The interplay between EBV and KSHV viral products and NF-kappaB pathway in oncogenesis","volume":"15","author":"Charostad","year":"2020","journal-title":"Infect. Agent Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fonc.2020.00600","article-title":"Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma","volume":"10","author":"Hau","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fonc.2019.00109","article-title":"Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders","volume":"9","author":"Crombie","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Naimo, E., Zischke, J., and Schulz, T.F. (2021). Recent Advances in Developing Treatments of Kaposi\u2019s Sarcoma Herpesvirus-Related Diseases. Viruses, 13.","DOI":"10.3390\/v13091797"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.3390\/v6114731","article-title":"KSHV targeted therapy: An update on inhibitors of viral lytic replication","volume":"6","author":"Coen","year":"2014","journal-title":"Viruses"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.18632\/oncotarget.27815","article-title":"Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism","volume":"11","author":"Calderon","year":"2020","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi\u2019s sarcoma and its associated herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.watres.2019.04.045","article-title":"Mechanistic insights into the reactivity of Ferrate(VI) with phenolic compounds and the formation of coupling products","volume":"158","author":"Chen","year":"2019","journal-title":"Water Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Granato, M., Gilardini Montani, M.S., Angiolillo, C., D\u2019Orazi, G., Faggioni, A., and Cirone, M. (2018). Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62\/SQSTM1. Viruses, 11.","DOI":"10.3390\/v11010008"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Granato, M., Gilardini Montani, M.S., Zompetta, C., Santarelli, R., Gonnella, R., Romeo, M.A., D\u2019Orazi, G., Faggioni, A., and Cirone, M. (2019). Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven B Cell Immortalization. Biomolecules, 9.","DOI":"10.3390\/biom9090482"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Sudomova, M., and Hassan, S.T.S. (2021). Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways. Microorganisms, 9.","DOI":"10.3390\/microorganisms9020292"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Sudomova, M., Berchova-Bimova, K., Marzocco, S., Liskova, A., Kubatka, P., and Hassan, S.T.S. (2021). Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. Viruses, 13.","DOI":"10.3390\/v13061014"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Wongchitrat, P., Shukla, M., Sharma, R., Govitrapong, P., and Reiter, R.J. (2021). Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection. Antioxidants, 10.","DOI":"10.3390\/antiox10010047"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/nyas.14005","article-title":"The role of melatonin in targeting cell signaling pathways in neurodegeneration","volume":"1443","author":"Shukla","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jama.2008.980","article-title":"Contracting schizophrenia: Lessons from the influenza epidemic of 1918-1919","volume":"301","author":"Yudofsky","year":"2009","journal-title":"JAMA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1038\/s41598-017-13591-x","article-title":"Serum SAA1 and APOE are novel indicators for human cytomegalovirus infection","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/alz.12008","article-title":"Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer\u2019s disease","volume":"16","author":"Linard","year":"2020","journal-title":"Alzheimers Dement."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lee, K.H., Kwon, D.E., Do Han, K., La, Y., and Han, S.H. (2020). Association between cytomegalovirus end-organ diseases and moderate-to-severe dementia: A population-based cohort study. BMC Neurol., 20.","DOI":"10.1186\/s12883-020-01776-3"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Talib, W.H., Alsayed, A.R., Abuawad, A., Daoud, S., and Mahmod, A.I. (2021). Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules, 26.","DOI":"10.3390\/molecules26092506"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12935-021-01892-1","article-title":"An updated review of mechanistic potentials of melatonin against cancer: Pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress","volume":"21","author":"Mehrzadi","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2147\/OTT.S298512","article-title":"Role and Therapeutic Potential of Melatonin in Various Type of Cancers","volume":"14","author":"Gurunathan","year":"2021","journal-title":"Onco Targets Ther."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Jaworek, A.K., Szepietowski, J.C., Halubiec, P., Wojas-Pelc, A., and Jaworek, J. (2021). Melatonin as an Antioxidant and Immunomodulator in Atopic Dermatitis-A New Look on an Old Story: A Review. Antioxidants, 10.","DOI":"10.20944\/preprints202106.0581.v1"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6641055","DOI":"10.1155\/2021\/6641055","article-title":"Melatonin Exerts Anti-Inflammatory, Antioxidant, and Neuromodulatory Effects That Could Potentially Be Useful in the Treatment of Vertigo","volume":"2021","author":"Guerra","year":"2021","journal-title":"Int. J. Otolaryngol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"101304","DOI":"10.1016\/j.arr.2021.101304","article-title":"Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer\u2019s disease neuropathology","volume":"67","author":"Hossain","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Santos-Ledo, A., Luxan-Delgado, B., Caballero, B., Potes, Y., Rodriguez-Gonzalez, S., Boga, J.A., Coto-Montes, A., and Garcia-Macia, M. (2021). Melatonin Ameliorates Autophagy Impairment in a Metabolic Syndrome Model. Antioxidants, 10.","DOI":"10.3390\/antiox10050796"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"686551","DOI":"10.3389\/fcell.2021.686551","article-title":"An Examination of the Putative Role of Melatonin in Exosome Biogenesis","volume":"9","author":"Amini","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Chok, K.C., Koh, R.Y., Ng, M.G., Ng, P.Y., and Chye, S.M. (2021). Melatonin Induces Autophagy via Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress Pathway in Colorectal Cancer Cells. Molecules, 26.","DOI":"10.3390\/molecules26165038"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"91402","DOI":"10.18632\/oncotarget.20592","article-title":"Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1\/p70S6K\/HIF-1alpha and hypoxia-mediated mitophagy","volume":"8","author":"Fondevila","year":"2017","journal-title":"Oncotarget"},{"key":"ref_89","first-page":"105","article-title":"The role of nanotechnology in the treatment of viral infections","volume":"4","author":"Singh","year":"2017","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_90","first-page":"646","article-title":"Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: Beyond chemotherapy treatment","volume":"4","author":"Shahid","year":"2021","journal-title":"Cancer Drug Resist."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Hwang, J., Suh, C.H., Won Kim, K., Kim, H.S., Armand, P., Huang, R.Y., and Guenette, J.P. (2021). The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. Cancers, 13.","DOI":"10.3390\/cancers13081785"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fonc.2019.00104","article-title":"Progress in EBV Vaccines","volume":"9","author":"Mautner","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Munz, C. (2019). Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice. Vaccines, 7.","DOI":"10.3390\/vaccines7040217"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"19255","DOI":"10.18632\/oncotarget.13770","article-title":"Novel Epstein-Barr virus-like particles incorporating gH\/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice","volume":"8","author":"Perez","year":"2017","journal-title":"Oncotarget"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1007\/s00018-020-03538-3","article-title":"Vaccination against the Epstein-Barr virus","volume":"77","author":"Ruhl","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"19141","DOI":"10.1073\/pnas.2002016117","article-title":"Targeting nanoparticles to the brain by exploiting the blood-brain barrier impermeability to selectively label the brain endothelium","volume":"117","author":"Liu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"10631","DOI":"10.1021\/acsomega.8b01445","article-title":"Nanoparticles Self-Assembly within Lipid Bilayers","volume":"3","author":"Chan","year":"2018","journal-title":"ACS Omega"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"677027","DOI":"10.3389\/fimmu.2021.677027","article-title":"The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1016\/j.vaccine.2019.04.071","article-title":"A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits","volume":"37","author":"Mulama","year":"2019","journal-title":"Vaccine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/s41598-020-61358-8","article-title":"A cost-effective polyethylene glycol-based method for the isolation of functional edible nanoparticles from ginger rhizomes","volume":"10","author":"Kalarikkal","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"18220","DOI":"10.1038\/s41598-020-75253-9","article-title":"Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood-brain barrier opening","volume":"10","author":"Ohta","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12989-018-0263-3","article-title":"Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation","volume":"15","author":"You","year":"2018","journal-title":"Part. Fibre Toxicol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2018.03.046","article-title":"Partitioning of dispersed nanoparticles in a realistic nasal passage for targeted drug delivery","volume":"543","author":"Dong","year":"2018","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11407\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:21:11Z","timestamp":1760167271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":103,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222111407"],"URL":"https:\/\/doi.org\/10.3390\/ijms222111407","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]}}}